is glp-1 r retatrutide Understanding the Next-Gen Weight Loss Drug: (GLP-1, GIP, and Glucagon Receptor Agonist) Retatrutide - Triple GLP-1R /

12:e70200

2, 3, 4 Neuroimaging studies have reported reduced vermis volume as well as total cerebellar volume, whereas post-mortem analyses have revealed a significant reduction in the number of Purkinje cells in individuals with autism

Urva S, Coskun T, Loh MT et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicenter, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

He dims lights at sunset, avoids screens as much as possible, and uses blue-light-blocking glasses when screen use is unavoidable

Research published in obesity journals shows that weight regain accelerates in the first 3-6 months after discontinuation because your body increases ghrelin production (the hunger hormone) while decreasing satiety hormones